Home | All results_reference

[RDF data]
Results Reference #1326

Resource URI: http://static.linkedct.org/resource/results_reference/1326
linkedct:citation Ortonne JP, Sterry W, Tasset C, Reich K. Safety and efficacy of subcutaneous certolizumab pegol, a new anti-TNF-alpha monoclonal antibody, in patients with moderate-to-severe chronic plaque psoriasis: preliminary results from a double-blind, placebo-controlled trial. J.Am.Acad.Dermatol. 56[Suppl 2], AB6. 2007. Washington, DC, 65th Annual Meeting of the American Academy of Dermatology (AAAD), February 2-7, 2007.
rdfs:label Results Reference #1326
is linkedct:results_reference of <http://static.linkedct.org/resource/trials/NCT00245765>
linkedct:results_reference_id 1326 (xsd:int)
rdf:type linkedct:results_reference